(Press-News.org) WASHINGTON, D.C., (Oct. 19, 2010) -- Bacteria have a natural ability to attach themselves to surfaces, both natural and synthetic. Once attached, they often work cooperatively to form biofilms, thin layers of bacterial colonies that can coat the surface of a medical device and introduce the risk of infection. As a result, orthopedic implants, catheters, and even contact lenses can become vehicles for infection.
Antibacterial materials on the surface can reduce the risk but generally these materials do not stick well to the devices. A research group at the University of South Australia is working on techniques to permanently bind antibacterial coatings to medical devices by binding them to a polymer layer. They present their research today at the AVS 57th International Symposium & Exhibition, which takes place this week at the Albuquerque Convention Center in New Mexico.
The Australian scientists start by applying a plasma polymer coating, a technique that works on many different base materials including glass, metal, and many polymers used in devices. This ultrathin film acts as a scaffold on which to bind materials that either signal the bacteria not to attach by interfering with the cell's attachment mechanism or that prevent multiplication once the bacteria are attached.
The presentation will compare several different antibiotics applied to the polymer film, including established antibiotic compounds, silver nanoparticles, and novel diterpene compounds derived from Australian plants that have been used in traditional medicine. Each approach has pros and cons that must be carefully weighed before using them on a device implanted in the human body.
"We believe that no solution will be universal so we want to establish an array of approaches," says Hans Griesser of the University of South Australia. "The new diterpene compounds that we are testing are structurally quite different from established antibacterial compounds, and they are effective against methicillin-resistant Staphylococcus aureus. That is what got us excited about them."
###
The presentation, "Some strategies and Results for Antibacterial Coatings" is at 2:40 p.m. on Tuesday, October 19, 2010.
ABSTRACT: http://www.avssymposium.org/Open/SearchPapers.aspx?PaperNumber=BI1-TuA-3
MORE INFORMATION FOR JOURNALISTS
The AVS 57th International Symposium and Exhibition is being held October 17-22, 2010, at the Albuquerque Convention Center, in Albuquerque, New Mexico. The meeting includes more than 1,200 talks and posters presented in more than 130 technical sessions. All meeting information, including directions to the Convention Center, can be found at:
http://www2.avs.org/symposium/
REGISTRATION -- Staff reporters and professional freelance journalists working on assignment are invited to attend the conference free of charge. Journalist registration instructions can be found at:
http://www2.avs.org/symposium/AVS57/pdfs/pressinvite.pdf
PRESS ROOM
The AVS press room will be located in East Lobby of the Albuquerque Convention Center. Press room hours are Monday-Thursday, 8:00 a.m. to 5:00 p.m. The phone number there is 408-205-0595. Press Kits containing company product announcements and other news will be available on CD-ROM in the press room. Also access the online press room at: http://www2.avs.org/symposium/AVS57/pages/press57.html
USEFUL LINKS
Complete Program: http://www2.avs.org/symposium/AVS57/pages/tech_program.html
Searchable abstracts: http://www.avssymposium.org/Open/SearchPapers.aspx
Topical Conferences: http://www2.avs.org/symposium/AVS57/pages/tech_topconf.html#EN
Meeting Home Page: http://www2.avs.org/symposium/
PLENARY SESSION
The plenary talk, "Carbon Nanotubes and Single Sheet Graphene," which will be at noon on Monday, October 18, 2010 in Ballroom B of the Albuquerque Convention Center. See: http://www2.avs.org/symposium/AVS57/pages/sessions_lecturer.html
SPECIAL TUTORIALS
AVS promotes communication, dissemination of knowledge, recommended practices, research, and education in a broad range of technologically relevant topics. One way that it does this is by offering special tutorials in areas such as:
- Graphene Tutorial (Sunday, October 17, 2010, 1:00-5:00 p.m.)
- Tutorial on Nanoparticle Characterization and Toxicity: Significant Challenges and Critical Needs (Sunday, October 17, 2010, 1:00-5:00 p.m.)
To access the complete descriptions of these special tutorials, see:
http://www2.avs.org/symposium/AVS57/pages/special_tutorials.html
ABOUT AVS
As a professional membership organization, AVS fosters networking within the materials, processing, and interfaces community at various local, national or international meetings and exhibits throughout the year. AVS publishes four journals, honors and recognizes members through its prestigious awards program, offers training and other technical resources, as well as career services.
END
WASHINGTON, D.C., (Oct. 19, 2010) -- In a laboratory at Ohio State University, an ongoing experiment is studying why batteries lose their ability to hold a charge as they age -- specifically lithium-ion batteries, which have generated a lot of buzz for their potential to power the electric cars of the future.
Preliminary results presented today at the AVS 57th International Symposium & Exhibition, taking place this week at the Albuquerque Convention Center in New Mexico, suggest that the irreversible changes inside a dead battery start at the nanoscale.
Yann Guezennec ...
How parasites use different life-history strategies to beat our immune systems may also provide insight into the control of diseases, such as elephantiasis and river blindness, which afflict some of the world's poorest communities in tropical South-East Asia, Africa and Central America. The research is due to be published next week in the online, open-access journal PLoS Biology.
The study, led by Dr Simon Babayan of the University of Edinburgh, showed using a mouse model of parasite infection (for diseases such as elephantiasis) that when the parasitic worms enter the ...
UPTON, NY — Many studies have suggested that genetic differences make some individuals more susceptible to the addictive effects of alcohol and other drugs. Now scientists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory provide the first experimental evidence to directly support this idea in a study in mice reported in the October 19, 2010, issue of Alcoholism Clinical Experimental Research.
The study compared the brain's response to long-term alcohol drinking in two genetic variants of mice. One strain lacked the gene for a specific brain receptor ...
In contrast to the findings of some studies and the recommendations that pregnant women increase their intake of fish oil via dietary docosahexaenoic acid (DHA) because of the possible benefits, a randomized trial that included more than 2,000 women finds that use of DHA supplements did not result in lower levels of postpartum depression in mothers or improved cognitive and language development in their offspring during early childhood, according to a study in the October 20 issue of JAMA.
"Epidemiological investigations from the United States and Europe demonstrate ...
Hospitals that had operating room personnel participate in a medical team training program that incorporates practices of aviation crews, such as training in teamwork and communication, had a lower rate of surgical deaths compared to hospitals that did not participate in the program, according to a study in the October 20 issue of JAMA.
Adverse events related to surgery continue to occur despite the best efforts of clinicians, according to background information in the article. In 2006, the Veterans Health Administration (VHA), the largest national integrated health ...
Follow-up of about 11 years of participants in the Women's Health Initiative finds that among postmenopausal women, use of estrogen plus progestin is associated with an increased incidence of breast cancers that are more advanced, and with a higher risk of deaths attributable to breast cancer, according to a study in the October 20 issue of JAMA.
In the Women's Health Initiative (WHI) randomized, placebo-controlled trial of estrogen plus progestin, after an average intervention time of 5.6 years and an average follow-up of 7.9 years, breast cancer incidence was increased ...
CHAPEL HILL – Researchers from the University of North Carolina at Chapel Hill School of Medicine have discovered a gene variant that may protect against alcoholism.
The variant, in a gene called CYP2E1, is associated with a person's response to alcohol. For the ten to twenty percent of people that possess this variant, those first few drinks leave them feeling more inebriated than the rest of the human population, who harbor a different version of the gene.
Previous studies had shown that people who react strongly to alcohol were less likely to become alcoholics ...
Children with permanent hearing impairment who received hearing screening as newborns had better general and language developmental outcomes and quality of life at ages 3 to 5 years compared to newborns who received hearing screening through behavioral testing, according to a study in the October 20 issue of JAMA.
Permanent childhood hearing impairment is a serious, relatively common condition. Auditory input is essential for development and social functioning, so early awareness of a child's hearing ability is important in creating opportunities for early amplification ...
Information provided to physicians from the US and around the world directly by pharmaceutical companies can be associated with higher prescribing frequency, higher costs, and lower prescribing quality. Furthermore, exposure to pharmaceutical company information does not improve physician prescribing behavior. These are the findings of a systematic review by Geoffrey Spurling from The University of Queensland, Brisbane, Australia, and colleagues and published in this week's PLoS Medicine.
After doing an extensive literature search, the authors analyze and describe the ...
Intracerebral haemorrhage (ICH) accounts for 10% and 20% of strokes in high and low-to-middle income countries respectively, but ICH incidence and case fatality do not seem to be declining. In a Health in Action paper published in this week's PLoS Medicine magazine, Colin Josephson, Rustam Al-Shahi Salman, and colleagues (from the University of Edinburgh) discuss the effectiveness of treatments for intracerebral haemorrhage. Despite the lack of decline in ICH incidence and case fatality, the authors find that evidence supports organised stroke unit care and secondary prevention ...
